Lethal-7 (let-7) microRNAs (miRNAs) are the most abundant miRNAs in the genome, but their role in developing thymocytes is unclear. We found that let-7 miRNAs targeted Zbtb16 mRNA, which encodes the lineage-specific transcription factor PLZF, to post-transcriptionally regulate PLZF expression and thereby the effector functions of natural killer T cells (NKT cells). Dynamic upregulation of let-7 miRNAs during the development of NKT thymocytes downregulated PLZF expression and directed their terminal differentiation into interferon-g (IFN-g)-producing NKT1 cells. Without upregulation of let-7 miRNAs, NKT thymocytes maintained high PLZF expression and terminally differentiated into interleukin 4 (IL-4)-producing NKT2 cells or IL-17-producing NKT17 cells. Upregulation of let-7 miRNAs in developing NKT thymocytes was signaled by IL-15, vitamin D and retinoic acid. Such targeting of a lineage-specific transcription factor by miRNA represents a previously unknown level of developmental regulation in the thymus.
T cell development in the thymus is regulated by both transcriptional and post-transcriptional control mechanisms. Transcriptional mechanisms of developmental regulation in the thymus have been intensively studied, which has resulted in the identification of lineage-specific transcription factors such as ThPOK, Runx3, Foxp3 and PLZF [1] [2] [3] [4] [5] [6] . In contrast, post-transcriptional regulatory mechanisms in the thymus have been less well studied 7 . However, the discovery of microRNAs (miRNAs) as post-transcriptional regulators of gene expression has substantially advanced the understanding of posttranscriptional regulation and its molecular basis 8 .
The potential importance of miRNAs for T cell development in the thymus was initially revealed by studies of dicer-deficient mice that are devoid of all miRNAs 9 . Dicer deficiency abrogates the generation of innate-like natural killer T cells (NKT cells), which would suggest that miRNAs are necessary for NKT cell development [10] [11] [12] . Innate-like NKT cells serve an important role in early host defenses against invading pathogens by rapidly secreting effector cytokines such as interleukin 4 (IL-4) and interferon-γ (IFN-γ) that provide early protection before a full-blown adaptive immune response can be mounted 13 . Innate-like NKT cells are unique in their expression of invariant αβ T cell antigen receptors (TCRs) with specificity for glycolipids presented by CD1d, a non-classical major histocompatibility complex class Ib molecule. They develop from immature CD4 + CD8 + double-positive (DP) thymocytes that are signaled by TCR engagement of CD1d-glycolipid ligands expressed on other DP thymocytes 13 , and their development is dependent on the zinc-finger transcription factor PLZF 5, 6 .
While dicer deficiency has illustrated the importance of miRNAs in the thymus, the specific miRNAs important for thymic development and the mechanisms by which miRNAs affect T cell differentiation remain unclear. The most abundant family of miRNAs in the genome is the let-7 family 14 . In mammals, the let-7 miRNA family consists of 12-14 individual members encoded on different chromosomes. Initially identified as a gene in Caenorhabditis elegans that encodes a product important for development 15 , let-7 has subsequently been found to encode miRNAs 16 that, in mammals, potentially target genes encoding products involved in various cellular functions, including cell-cycle progression, oncogenesis and metabolism [17] [18] [19] [20] [21] . Interestingly, hematopoietic cells in fetal mice express two proteins, LIN28A and LIN28B, that prevent the biogenesis of functional let-7 miRNAs [22] [23] [24] [25] [26] and are responsible for the fetal pattern of lymphopoiesis 27 . LIN28 proteins bind specifically to let-7 precursor molecules and thereby prevent their being processed into functional let-7 miRNAs and promote their degradation [22] [23] [24] [25] [26] . In addition to binding to immature let-7 molecules and inhibiting the biogenesis of functional let-7 miRNAs, LIN28 proteins bind to certain mRNAs that encode proteins in the secretory pathway [28] [29] [30] . Nevertheless, the fact that the inhibition of let-7 miRNAs by LIN28 is limited to only fetal hematopoietic cells suggests that uninhibited expression of let-7 miRNAs might be important for hematopoietic cell development in post-natal mice.
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A r t i c l e s
We undertook the present study to specifically assess posttranscriptional regulation of T cell differentiation by let-7 miRNAs in the post-natal thymus. We found that let-7 miRNAs targeted Zbtb16 mRNA (which encodes PLZF) to post-transcriptionally inhibit the expression of PLZF protein. During NKT cell development, let-7 expression was dynamically upregulated, which caused the expression of PLZF protein to be downregulated to levels that directed NKT cells to terminally differentiate into IFN-γ-producing NKT1 cells rather than IL-4-producing NKT2 cells or IL-17-producing NKT17 cells. Moreover, we demonstrated that upregulation of let-7 during NKT cell differentiation was signaled in the thymic medulla by exogenous stimuli such as IL-15, vitamin D and retinoic acid. Thus, posttranscriptional regulation of PLZF by let-7 miRNAs determined the effector function of NKT cells, which provides a new perspective on NKT cell differentiation in the thymus. Our study identifies the targeting of a lineage-specific transcription factor by miRNA as a previously unrecognized level of developmental regulation in the thymus.
RESULTS
let-7 miRNAs are expressed in thymocytes and T cells
To investigate a possible regulatory role for let-7 miRNAs during T cell differentiation, we first assessed the expression of individual members of the let-7 miRNA family in developing T cells and found that let-7 miRNAs were expressed in all thymocyte subsets and lymph node T cells (Fig. 1a) . The total abundance of let-7 miRNAs increased during the differentiation of CD4 − CD8 − double-negative (DN) thymocytes into pre-selection DP thymocytes and further increased during differentiation into post-selection intermediate and CD4 + or CD8 + single-positive (SP) thymocytes (Fig. 1a) .
To determine if let-7 miRNAs influenced thymocyte development, we examined the developmental consequences of quantitatively reducing let-7 expression. Because individual members of the let-7 miRNA family are dispersed throughout the genome, our strategy for reducing let-7 expression in thymocytes took advantage of the ability of LIN28A and LIN28B fetal proteins to bind to the extended loop region of let-7 precursor molecules and prevent their being processed into functionally mature miRNAs. We constructed transgenes consisting of cDNA encoding Flag-tagged LIN28A or LIN28B protein under the control of T cell-specific human CD2 promoter-enhancer elements to drive the expression of LIN28 proteins specifically in thymocytes and T cells (Fig. 1b) . Reflecting the initial onset of CD2-driven transgene expression in thymocytes at the DN stage of differentiation 31 , the expression of individual let-7 miRNA family members was reduced in DN thymocytes from mice with transgenic expression of LIN28 proteins (called 'LIN28-transgenic' mice here) and was reduced even more in LIN28-transgenic thymocytes at later stages (i.e., DP and SP stages) of differentiation (Fig. 1c) . The major exception was an individual member of the let-7 family, let-7c, whose expression was relatively resistant to transgenic expression of LIN28 (Fig. 1c) . When we examined the LIN28-binding sequences in the extended loop region of immature let-7c precursor molecules, we found that let-7c-2 precursor molecules were the only members of the family with a downstream LIN28-binding sequence (U-G-C-G) that deviated from the optimal downstream binding motif (G-G/A-A-G) (Fig. 1d) . Even with this exception, overall expression of let-7 miRNAs was significantly reduced in both LIN28A-transgenic thymocytes and LIN28B-transgenic thymocytes, with the transgenically expressed LIN28A being marginally more effective in reducing let-7 expression than the transgenically expressed LIN28B (Fig. 1e) . Thus, let-7 expression was substantially lower in LIN28A-transgenic and LIN28B-transgenic thymocytes than in wild-type thymocytes.
let-7 deficiency increases IL-4 + PLZF hi thymocytes
Thymocyte subpopulations defined by their expression of CD4 and CD8 (i.e. DN, DP and SP) were minimally altered in LIN28-transgenic mice (Fig. 2a) , with a reduction of ~30% in the absolute number of DP thymocytes in these mice (Fig. 2a) , suggestive of intra-thymic stress. Because we observed similar phenotypes in LIN28A-transgenic mice and LIN28B-transgenic mice, we used mainly LIN28A-transgenic mice for subsequent experiments. More detailed examination revealed that LIN28A-transgenic CD4 − CD8 + SP (SP8) thymocytes were CD44 hi CD122 hi Eomes hi memory-like cells, npg whereas wild-type SP8 thymocytes were CD44 lo CD122 lo Eomes lo naive cells (Fig. 2b) . To determine if the memory-like phenotype of LIN28A-transgenic SP8 thymocytes resulted from intra-thymic IL-4 signals 32 , we generated LIN28A-transgenic mice with homozygous deficiency in the receptor for IL-4, in which LIN28A-transgenic thymocytes would be unresponsive to intra-thymic IL-4. SP8 thymocytes in IL-4 receptor-deficient LIN28A-transgenic mice displayed a naive CD44 lo CD122 lo Eomes lo phenotype (Fig. 2b) , which indicated that the appearance of memory-like SP8 thymocytes was a secondary consequence of increased IL-4 signaling in the LIN28-transgenic thymus.
To understand why IL-4 signaling was increased in LIN28A-transgenic thymuses, we quantified IL-4-producing thymocytes in wild-type and LIN28A-transgenic mice. As determined by enzymelinked immunospot assay, the number of IL-4-producing thymocytes was five-to tenfold greater in LIN28A-transgenic thymuses than in wild-type thymuses (Fig. 2c) . Because IL-4-producing thymocytes have high expression of PLZF 32 , we quantified PLZF hi thymocytes and found that their number was also five-to tenfold greater in LIN28A-transgenic thymuses than in wild-type thymuses (Fig. 2c) . Notably, the generation of IL-4-producing LIN28A-transgenic thymocytes required PLZF expression, as IL-4-producing LIN28A-transgenic thymocytes did not arise in mice with homozygous nonsense mutation of the gene encoding PLZF that results in PLZF deficiency (Zbtb16 LU/LU ) (Fig. 2d) . Thus, transgenic expression of LIN28 markedly increased the number of PLZF hi thymocytes that produced IL-4, and it was the excess production of IL-4 that stimulated the appearance of memory-like SP8 thymocytes in LIN28-transgenic mice.
let-7 miRNAs target Zbtb16 mRNA to reduce PLZF expression Given the increased number of PLZF hi thymocytes in LIN28-transgenic mice, we considered that let-7 miRNAs might target Zbtb16 mRNA to inhibit expression of its protein product, PLZF. Consistent with such a possibility, computational analysis identified two evolutionarily conserved let-7 miRNA-binding sites in the 3′ untranslated region (UTR) of Zbtb16 mRNA (Fig. 3a) . To determine if let-7 miRNAs target the 3′ UTR of Zbtb16 mRNA and inhibit the synthesis of PLZF protein, we transfected 293T human embryonic kidney cells with luciferase-encoding mRNA whose 3′ UTR was derived from Zbtb16 and simultaneously co-transfected the cells with either let-7 miRNA or control miRNA with a scrambled sequence. Co-transfection of let-7 miRNA significantly reduced luciferase activity compared with that of cells co-transfected with the control miRNA ( Fig. 3b) , which demonstrated that let-7 miRNAs targeted the 3′ UTR of Zbtb16 mRNA.
Because PLZF is the lineage-determining transcription factor for NKT cells and innate γδ T cells 5, 6, 33 , we measured the expression of Zbtb16 mRNA and PLZF protein and found that the expression of each was substantially higher in innate thymocytes from LIN28A-transgenic mice than in those from wild-type mice (Fig. 3c) . To investigate if PLZF expression was increased in LIN28A-transgenic innate thymocytes specifically because they were relatively let-7 deficient, we acutely increased the let-7 content of LIN28A-transgenic thymocytes with a doxycycline-inducible transgene that encodes modified pre-let-7 molecules lacking LIN28-binding sequences (iLet7 ∆Lin28 ) 21 . The induction of transgenically expressed let-7 miRNA by short-term administration of doxycycline reduced PLZF expression in NKT thymocytes and γδ innate thymocytes and reduced the frequency of memory-like Eomes + SP8 thymocytes in LIN28A-transgenic iLet7 ∆Lin28 mice (Fig. 3d,e) . Thus, these findings documented that reduced expression of let-7 miRNAs was responsible for increased PLZF expression in LIN28-transgenic thymocytes, and identified let-7 miRNAs as specific inhibitors of PLZF expression.
Endogenous let-7 does not affect overall NKT thymocyte numbers
We next investigated whether endogenous let-7 miRNAs reduced the overall generation of NKT cells in the thymus, in addition to preventing the excessive generation of IL-4-producing NKT cells. By staining with the NKT cell-specific tetramer CD1d-PBS57, we found npg A r t i c l e s that the total number of NKT thymocytes was very similar in LIN28-transgenic and wild-type mice, although the total number of NKT cells in the periphery varied slightly (Fig. 4a) . One possible reason for the finding that the overall number of NKT thymocytes was not reduced by transgenic expression of LIN28 proteins might be that endogenous let-7 miRNAs were expressed in insufficient amounts, relative to PLZF, in precursor NKT thymocytes to prevent their initial commitment to differentiate into innate-lineage NKT cells.
To determine if higher let-7 expression would reduce the overall number of NKT thymocytes, we increased the let-7 content of thymocytes in wild-type mice with the doxycycline-inducible iLet7 ∆Lin28 transgene described above. In these experiments, we reconstituted lethally irradiated host mice with a mixture of bone marrow cells from donor C57BL/6 (B6) CD45.1 + mice and donor iLet7 ∆Lin28 CD45.2 + mice and provided doxycycline continuously in the drinking water from day 2 after bone marrow reconstitution until we analyzed the mice 8 weeks later (Fig. 4b and Supplementary Fig. 1 ). As determined by staining with the CD1d-PBS57 tetramer, doxycycline treatment abrogated the generation of NKT thymocytes from iLet7 ∆Lin28 donor cells but had no effect on the generation of NKT thymocytes from wild-type B6 donor cells within the same thymus (Fig. 4b) . Thus, higher expression of let-7 miRNAs quantitatively inhibited the generation of NKT thymocytes and did so in a cell-intrinsic manner.
Next we sought to determine if endogenous amounts of let-7 would be sufficient to impair the generation of NKT thymocytes in mice with reduced PLZF expression. We used heterozygous Zbtb16 +/LU mice, which produce PLZF from only one wild-type allele 6 ; these mice had considerably fewer CD1d-PBS57 tetramer-positive NKT thymocytes than did wild-type mice (Fig. 4c) . Introduction of the LIN28A-encoding transgene into Zbtb16 +/LU mice generated LIN28A-transgenic Zbtb16 +/LU mice in which the frequency and number of NKT thymocytes were 50-fold higher than that of Zbtb16 +/LU mice and their PLZF content, as determined by intracellular staining, was tenfold higher than that of Zbtb16 +/LU mice (Fig. 4c) . These results indicated that endogenous let-7 miRNAs were sufficient to inhibit the generation of NKT thymocytes in Zbtb16 +/LU mice (with heterozygous expression of PLZF) but were not sufficient to inhibit the generation of NKT thymocytes in Zbtb16 +/+ mice (with homozygous expression of PLZF). Thus, it was the relative amount of let-7 versus PLZF that controlled the overall number of NKT thymocytes generated in the thymus.
let-7 modulates terminal NKT cell differentiation
To gain greater insight into the physiological role of let-7 miRNAs during the differentiation of NKT thymocytes, we examined the kinetics of expression of PLZF and let-7 in developing NKT thymocytes 34 . Among CD24 lo thymocytes, the differentiation of NKT cells proceeded through three distinct stages phenotypically distinguished by expression of CD44 and NK1.1, as follows: stage-1 cells were CD44 − NK1.1 − precursor NKT cells; stage-2 cells were CD44 + NK1.1 − cells that produced mainly IL-4; and stage-3 cells were CD44 + NK1.1 + cells that produced mainly IFN-γ (Fig. 5a) .
Analysis of thymocytes at various stages of differentiation revealed that the expression of Zbtb16 mRNA was high in NKT cells at stages 1 and 2 but was downregulated in NKT cells at stage 3 (Fig. 5b) . In contrast, endogenous expression of let-7 miRNAs was initially low in NKT cells at stages 1 and 2, but it was upregulated in NKT cells at stage 3 (Fig. 5b) . Thus, the expression of both PLZF and let-7 dynamically changed during the development of NKT thymocytes but did so in reciprocal directions. To determine if the downregulation of Zbtb16 mRNA in NKT cells at stage 3 was caused by upregulation of let-7, we performed a similar analysis with A r t i c l e s LIN28-transgenic thymocytes and discovered that NKT thymocytes in LIN28-transgenic mice differentiated into stage-2 (CD44 + NK1.1 − ) cells but not stage-3 (CD44 + NK1.1 + ) cells (Fig. 5c) , which indicated that the downregulation of Zbtb16 mRNA did not occur in LIN28-transgenic mice. The profound block in differentiation into stage 3 and the subsequent increase in the frequency of cells at stage 2 in LIN28-transgenic mice were specific consequences of reduced expression of let-7 miRNAs because normal differentiation into stage-3 cells was restored in LIN28-transgenic mice by induction of the doxycycline-inducible iLet7 ∆Lin28 transgene to increase let-7 expression (Fig. 5c) . Thus, reduced expression of let-7 miRNAs resulted in persistently high expression of PLZF, which prevented the differentiation of NKT cells into stage 3 and resulted instead in their terminal differentiation into functional NKT cells at stage 2. We concluded that the downregulation of PLZF during the development of NKT thymocytes was post-transcriptionally induced by let-7 miRNAs and was required for the terminal differentiation of NKT thymocytes into stage 3. To assess the effect of let-7 on the generation of these three NKT effector lineages, we analyzed the expression of transcription factors by intracellular staining for PLZF, RORγt and T-bet in NKT thymocytes from wild-type and LIN28A-transgenic mice (Fig. 6) .
In wild-type mice, NKT thymocytes consisted mostly (>60%) of NKT1 (PLZF lo RORγt − T-bet + ) effector cells, whereas in LIN28-transgenic mice, NKT thymocytes consisted mostly (>70%) of NKT2 (PLZF hi RORγt − T-bet − ) effector cells and NKT17 (PLZF hi-int RORγt + T-bet − ) effector cells (Fig. 6a) . However, expression of the cytokine receptors IL-17RB and CD122 on various NKT effector lineages was unaffected by expression of the LIN28 transgene (Fig. 6b) . These results indicated that let-7 miRNAs were needed for developing NKT thymocytes to terminally differentiate into NKT1 effector cells rather than NKT2 or NKT17 effector cells. The thymic bias toward NKT2 and NKT17 differentiation in LIN28-transgenic mice was less evident in the lymphoid periphery (lymph node and spleen) and was least evident in the liver (Fig. 6c b a , and absolute number of NKT thymocytes in those mice (right). Numbers adjacent to outlined areas (left) indicate percent CD1d-PBS57 + cells (NKT thymocytes) among total thymocytes. NS, not significant; *P < 0.05, **P < 0.01 and ***P < 0.001, compared with wild-type (Student's two-tailed t-test). Data are from nine independent experiments (a; mean and s.e.m. of n = 9 wild-type mice, n = 6 LIN28A-transgenic mice and n = 7 LIN28B-transgenic mice (thymus); n = 7 wild-type mice, n = 5 LIN28A-transgenic mice and n = 7 LIN28B-transgenic mice (lymph nodes); and n = 3 wild-type mice, n = 2 LIN28A-transgenic mice and n = 3 LIN28B-transgenic mice (liver)), are representative of four experiments (b) or are from three independent experiments (c; mean and s.e.m. of n = 3-6 mice per genotype). 
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A r t i c l e s and Supplementary Fig. 2 ), presumably as a result of differential migration and expansion of different NKT effector lineages after emigration from the thymus. Most notably, NKT cells in the liver of LIN28-transgenic mice were predominantly NKT1 cells ( Fig. 6c and Supplementary Fig. 2) , an observation similar to that of wildtype BALB/c mice 36 . Thus, let-7 miRNAs were key regulators of the terminal differentiation of NKT cells in the thymus, but additional (probably homeostatic) mechanisms affected the frequency of NKT cell effector populations in the periphery.
mTEC-derived signals upregulate let-7 in NKT thymocytes
Next we investigated the signals that induce the upregulation of let-7 in developing NKT thymocytes. To investigate the possibility that the upregulation of let-7-encoding genes on different chromosomes was coordinated by exogenous stimuli in the thymic medulla, we performed computational analyses to identify let-7-associated conserved noncoding sequences that were conserved between humans and mice (Fig. 7a) . We searched let-7-associated conserved noncoding sequences for the presence of binding motifs for members of the STAT ('signal transducer and activator of transcription') family, the vitamin D receptor (VDR) and retinoic acid receptors (RARs) for the following two reasons: the expression of let-7-encoding genes in nematodes is upregulated by the steroid receptor DAF-12, whose mammalian homologs are VDR and RAR 37, 38 ; and the differentiation of NKT thymocytes requires IL-15, which signals the translocation of STAT5 molecules to the nucleus, where they activate gene expression. 
A r t i c l e s
This search identified 121 different let-7-associated conserved noncoding sequences that contained multiple binding sequences for STAT, VDR and RAR (Fig. 7a) .
To determine if signals in the thymic medulla could induce let-7 expression in NKT thymocytes, we investigated whether medullary thymic epithelial cells (mTECs), which support the differentiation of NKT cells 39, 40 , expressed ligands or inducers of STAT, VDR and RAR. mTECs expressed mRNAs encoding the cytokine IL-15 (which signals through STAT5), the enzyme Cyp27b1 (which produces the active form of vitamin D) 41 and the enzyme Aldh1a2 (which produces the active form of retinoic acid) 41 (Fig. 7b) . In turn, CD1d tetramer-positive NKT thymocytes expressed Il2rb mRNA (which encodes CD122, the limiting component of surface receptors for IL-15), as well as mRNAs encoding VDR and the RAR family members RARA, RARG, RXRA and RXRB 41 (Fig. 7c) .
In addition, ex vivo stimulation of CD44 hi NK1.1 − PLZF hi NKT cells at stage 2 with IL-15, vitamin D3 and/or retinoic acid substantially upregulated the expression of let-7 miRNAs and reduced the expression of Zbtb16 mRNA (Fig. 7d) . This experimentally demonstrated that these stimuli signaled developing NKT thymocytes at stage 2 to upregulate the expression of let-7 miRNAs and downregulate the expression of PLZF.
We concluded that thymocytes phenotypically at stage 2 (CD44 hi NK1.1 − PLZF hi ) included developmentally intermediate cells with the potential to terminally differentiate into alternative effector cell fates: if the expression of let-7 miRNAs was upregulated, PLZF expression was downregulated and NKT thymocytes terminally differentiated into NKT1 effector cells; if the expression of let-7 miRNAs was not upregulated, PLZF expression was not downregulated and NKT thymocytes terminally differentiated into NKT2 and NKT17 effector cells (Supplementary Fig. 3 ).
DISCUSSION
Our study has identified a previously unknown level of developmental regulation in the thymus that is mediated by targeting of a lineagespecifying transcription factor by endogenous miRNA. Our study has shown that let-7 miRNAs targeted the 3′ UTR of Zbtb16 mRNA to inhibit the expression of PLZF protein, the zinc-finger transcription factor that is required by innate-lineage T cells for their generation in the thymus. However, endogenous let-7 miRNAs were not expressed in sufficient amounts relative to that of PLZF to interfere with the initial commitment of precursor thymocytes to differentiate into innate-like NKT cells. However, as NKT thymocyte differentiation progressed, endogenous let-7 miRNA expression was dynamically upregulated to levels that downregulated the expression of PLZF, with the result that developing NKT thymocytes terminally differentiated into NKT1 cells that produced mainly IFN-γ. Without upregulation of the expression of let-7 miRNAs, PLZF expression remained high throughout NKT thymocyte differentiation and resulted in their terminal differentiation into IL-4-producing NKT2 cells and IL-17-producing NKT17 cells. Thus, dynamic upregulation of the expression of let-7 miRNAs during NKT development was required for terminal differentiation into NKT effector cells that produced mainly IFN-γ instead of IL-4 or IL-17. Dynamic upregulation of the expression of let-7 miRNA was signaled by exogenous stimuli such as IL-15, vitamin D and retinoic acid in the thymic medulla. We conclude that endogenous let-7 miRNAs, by downregulating PLZF expression, regulate the terminal differentiation and cytokine effector function of NKT cells.
The let-7 family of miRNAs consists of individual members encoded by different genes on different chromosomes 14 . Each gene encoding a member of the let-7 family transcribes precursor miRNA molecules with seed regions that specifically bind to a spectrum of mRNAs that are targets of let-7 miRNAs, such as Zbtb16 mRNA 24 . A study using retroviral transduction of cDNA encoding LIN28 into adult bone marrow cells has demonstrated that LIN28 proteins impose a fetal pattern of T lymphopoiesis and B lymphopoiesis onto adult retrogenic mice, including increased numbers of NKT cells and memoryphenotype SP8 thymocytes 27 . Through experiments using transgenes to force the expression of LIN28 proteins in post-natal thymocytes, our study has supported those observations and extended them to substantially enhance the understanding of NKT cell differentiation. Notably, our study has shown that PLZF expression had to be actively downregulated for developing NKT thymocytes to differentiate into IFN-γ-producing NKT cells and that the downregulation of PLZF was post-transcriptionally induced by let-7 miRNAs.
The mechanism by which let-7 miRNA-encoding genes are coordinately upregulated at stage 2 of NKT thymocyte differentiation merits consideration. We found that developing NKT thymocytes at differentiation stage 2 upregulated the expression of let-7 miRNAs in response to stimulation by active vitamin D, retinoic acid and/or IL-15. The involvement of signaling via VDR in the upregulation of let-7 during the development of NKT thymocytes explains two published observations relating vitamin D and the development of NKT cells 42, 43 . First, such upregulation occurs in NKT cells at stage 2 with high surface expression of CD44, and surface CD44 proteins have been shown to bind a serum protein known as 'vitamin D-binding protein' , which is the main carrier of active vitamin D 42 . Second, VDR deficiency partially arrests NKT thymocyte development at stage 2 of differentiation 43 , although an additional effect of VDR deficiency is diminished IL-4 production relative to that in wild-type mice 44 . Thus, we suggest that VDR signaling contributes to the upregulation of let-7 in NKT cells at stage 2 because they are CD44 hi and can access vitamin D by binding soluble vitamin D-binding protein.
PLZF is the transcription factor responsible for the differentiation of innate-lineage T cells, but its pattern of expression during innate-lineage differentiation is unlike that of other lineage-specifying transcription factors in the thymus. RUNX3 and ThPOK specify cytotoxic-lineage differentiation and helper-lineage differentiation, respectively, but the expression of neither transcription factor decreases during lineagespecific differentiation in the thymus. That is, RUNX3 expression continually increases throughout the differentiation of CD8 + lineagecommitted thymocytes into functional CD8 + cytotoxic T cells 2, 45 , and ThPOK expression continually increases throughout differentiation of CD4 + lineage-committed thymocytes into mature CD4 + helper T cells 3, 4, 45 . In contrast, PLZF expression decreases during lineagespecific differentiation as a result of post-transcriptional regulation by let-7 miRNAs. Thus, the unusual activity of PLZF as a lineage-specific transcription factor is due to let-7. Notably, our study also explains why a transgene encoding PLZF has been found to skew the development of NKT thymocytes toward IL-4-producing NKT2 cells 46 ; i.e., because the PLZF-encoding transgene encoded Zbtb16 cDNA lacking the let-7 target sequence, so PLZF expression could not be downregulated.
Our study suggests that phenotypically CD44 hi NK1.1 − PLZF hi thymocytes at stage 2 of differentiation actually consist of two distinct subsets at different stages of development: 'intermediate' cells at stage 2 are immature cells that terminally differentiate into various effector cell fates (NKT2, NKT17 or NKT1) depending on let-7 expression, whereas 'mature' cells at stage 2 are terminally differentiated NKT2 or NKT17 effector cells. In our perspective, intermediate cells at stage 2 are the cells in which NKT effector fate is 'decided' on the basis of their PLZF expression levels. Persistence of PLZF expression drives npg these cells to terminally differentiate into IL-4-producing NKT2 cells and IL-17-producing NKT17 cells, whereas let-7 miRNA-induced downregulation of PLZF expression drives these cells to terminally differentiate into IFN-γ-producing NKT1 cells.
In conclusion, the inhibition of PLZF expression by let-7 miRNAs is a necessary component of NKT thymocyte development, with NKT cells acquiring different effector functions depending on whether PLZF expression is downregulated by let-7 miRNAs or not. As a secondary consequence of their regulation of the effector function of NKT cells, let-7 miRNAs also affect the differentiation of SP8 thymocytes into either naive CD8 + cytotoxic T cells or memory-like CD8 + cytotoxic T cells. Thus, targeting of the innate-lineage transcription factor PLZF by endogenous let-7 miRNAs is an important mechanism of developmental regulation in the thymus.
METhODS
Methods and any associated references are available in the online version of the paper. Prediction of miRNA targets and alignment of let-7 miRNA-encoding genes. The following websites were used for this: TargetScan (http://www. targetscan.org/mmu_61/) (release 6.2) for the prediction of let-7 miRNAs that target PLZF-encoding mRNA, and VISTA (http://genome.lbl.gov/vista/ index.shtml) for analysis of conservation between human and mouse genomic regions containing let-7 miRNA-encoding genes. The Genomatics software package was used for the prediction of nuclear factor-binding motifs in these conserved regions.
Luciferase assay. For measurement of luciferase activity, 293T cells were co-transfected with the vector Zbtb16-3′UTR hLuc-hRLuc (GeneCopoeia) and either control microRNA with a scrambled sequence or let-7 miRNAcontaining vectors, through the use of Lipofectamine 2000 (Invitrogen). Luciferase activity was assessed after 48 h with the Luc-Pair miR Luciferase Assay Kit (GeneCopoeia).
Isolation of RNA and quantitative PCR. Total RNA was isolated with an miRNeasy Mini Kit (Qiagen), and genomic DNA was digested with a DNA-free kit (Ambion). cDNA was synthesized with a SuperScript III kit (Invitrogen) with oligo(dT) priming, and amplification of gene-specific products was achieved with TaqMan probes (Applied Biosystems), listed in Supplementary 
